Results for the six months ended 30 June 2026

Summary by AI BETAClose X

Pathos Communications plc reported strong half-year results for the period ending June 30, 2026, with revenue increasing by 14% to US$7.3 million and adjusted EBITDA growing by 36% to US$1.7 million, alongside a 3.87% increase in adjusted EBITDA margin to 23.65%. The company also saw a significant increase in cash receipts from customers, up over 80% to US$7.9 million, and reported net cash of US$5.9 million. These positive financial outcomes are attributed to successful investments in workforce and operations, including a 30% increase in new client sign-ups following sales team restructuring and early positive signs from the new Asia Pacific operation. The company is also advancing its AI platform, Pressella, and PathosMind, with a confident outlook for meeting or exceeding full-year market expectations.

Disclaimer*

Pathos Communications PLC
09 September 2026
 

9 September 2026

  

Pathos Communications plc

 

Half Year Results for the six months ended 30 June 2026

 

Strong growth in revenue, profits and margins;

Benefits of H1 2026 investments now being realised

 

Pathos Communications plc (AIM: NEWS), the leading PR technology business, announces its unaudited interim results for the six months ended 30 June 2026.

US$000

H1 2026

H1 2025

% change

Revenue

7,339

6,420

14%

Gross profit

5,207

5,196

-     

Adjusted EBITDA

1,732

1,271

36%

Adjusted EBITDA margin

23.65%

19.8%

+3.87%

Profit before tax (reported)

964

759

27%

 

Financial Highlights

·    Double digit percentage growth in revenue and adjusted EBITDA

Revenue of US$7.3 million (H1 2025: US$6.4 million), an increase of 14%

Adjusted EBITDA 1 of US$1.7 million (H1 2025: US$1.3 million), an increase of 36%

·    Strong cash generation

Cash receipts from customers of US$7.9 million (H1 2025: US$ 4.3 million), an increase of over 80% demonstrating improved quality in the sources of revenue

Net cash of US$5.9 million (30 June 2025: $0.8 million; 31 December 2025: US$6.2 million)

 

Strategic and Operational highlights

·    Strengthening client relationships as the Company scales

Repeat customers represented 36% of H1 2026 revenue (H1 2025: 16%)

Recent run rate of new contracts signed in the repeats business tracking at over 75% of the current 2027 revenue market expectation on an annualised basis 2

Largest ever customer contract, a US$0.7 million one-year contract, won in May 2026

·    Successful investment in workforce

New sales team management structure increased new client sign-ups by approximately 30% following inception

Launch of dedicated Asia Pacific (APAC) operation showing early, positive signs

·    Ongoing innovation and geographic expansion

New products, including podcast services, book publishing and slots on prime business TV channels

24-month agreement signed with one of the "Big Three" US news periodicals

Pressella (Pathos's AI virtual publicist) and PathosMind development on track to be offered to all clients in H1 2027.

 

Current Trading and Outlook

As announced on 27 July 2026, the work undertaken and the investments made during H1 2026 has positioned Pathos for accelerated growth in the second half. This is now being evidenced, with a record revenue month in July and trading to the end of August also significantly ahead of the prior year.

 

The Board is particularly excited about the progress made with Pressella and PathosMind, which are on track for being generally available during H1 2027.  The Directors believe that the successful rollout of this technology, resulting in the provision of a virtual publicist becoming available to SMEs worldwide, will transform both their PR capabilities as well as the business opportunity for Pathos.

 

The Board therefore remains confident in the Company meeting, or being slightly ahead of, full year market expectations2 and is very optimistic about the future.

 

Omar Hamdi, Founder and Chief Executive Officer, commented:

"H1 2026 has been a period of strong delivery for Pathos with revenue, profits and cash receipts all increasing while we continued to invest the proceeds of our successful IPO behind the next phase of growth. The period saw us broaden our product offering, secure strategic publisher partnerships, strengthen our sales organisation and continue to advance Pressella, our proprietary AI platform, which we believe has the potential to transform both our operations and customer acquisition capabilities."

 

 

Investor Presentation

Omar Hamdi, Chief Executive Officer, and Adam Hurst, Chief Financial Officer, will host a live presentation and Q&A via Investor Meet today, 9 September 2026, at 10:00am BST. The presentation can be accessed via: https://www.investormeetcompany.com/pathos-communications-plc/register-investor

 

Notes:

1 Earnings before Interest, Tax, Depreciation and Amortisation adjusted for share-based payments and, in the prior year, one-off non-recurring costs incurred in the lead up to the IPO

2 Market expectations for FY 2026: Revenue of US$14.0 million and Adjusted EBITDA of US$4.0 million; 2027: Revenue of US$15.3 million.

 

For additional information, please contact:

 

Pathos Communications plc

Omar Hamdi - CEO

Adam Hurst - CFO

Mark James - Investor relations      

 

 

 

 

 

 

mark@investor-reach.com

Strand Hanson Limited (Nominated & Financial Adviser)

James Harris

Rob Patrick

Edward Foulkes

 

+44 (0)20 7409 3494

Cavendish Capital Markets Limited (Broker)

Stephen Keys / George Lawson / Elysia Bough - Corporate Finance

Michael Johnson / Sunila de Silva - Sales and ECM

 

+44 (0)20 7908 6000



About Pathos

Pathos Communications is a technology-enabled, human-led PR company that was established to democratise SMEs' access to established news publications to fuel their business growth. The Company operates a differentiated approach to the traditional PR model of long-term subscription fees, by offering a "pay-on-results" model, thereby providing an opportunity for the over 400 million SMEs globally, which typically have lower PR budgets.

Business and Financial Review

 

Pathos is pleased to report a strong first six months as a public company.

 

Double digit percentage revenue growth with new products and broader distribution

Revenue for H1 2026 was $7.3 million, an increase of 14% on the prior year (H1 2025: $6.4 million) reflecting ongoing product innovation and scaling of the Company's sales channels.  Gross margin in H1 2026 of 71% was ahead of H2 2025 of 69% (H1 2025 81%) and on an improving trajectory following refocus in H2 2025 to increase weighting of placements in premium media outlets to drive client retention.

 


H1 2026

$m

H1 2025

 $m

Revenue

7.33

6.42

Gross profit

5.21

5.20

Gross margin (%)

71%

81%

Administrative expenses (underlying)

(3.20)

(2.38)

Bad debt expense

(0.28)

(1.55)

Adjusted EBITDA 1

1.73

1.27

 

1 The Company reports both statutory (reported) and adjusted profitability measures as the Board considers adjusted metrics to provide a more useful indication of underlying operational performance.

 

Growth in profits and margins

Adjusted EBITDA increased by 36% compared to the same period in 2025, up to $1.7 million (H1 2025: $1.3 million). This was delivered despite investments made in growth initiatives during H1 2026, and also the increased head office cost base following the IPO in December 2025.  The expansion in adjusted EBITDA margin from 20% in H1 2025 to 24% in H1 2026 reflects both the ongoing effects of operational gearing as the Company continues to grow revenues, the greater opportunities being driven by the Company's ongoing technological innovation and significantly reduced bad debt write offs following the introduction of new processes in H1 2025.

 

Product innovation

During H1 2026, Pathos continued to diversify its offering, including the introduction of podcast services, book publishing and access to TV slots on a number of well-known business channels.  Pathos also entered into a strategic 24-month agreement with one of the "Big Three" US news periodicals, establishing a new relationship with a tier-one publisher and continuing to increase the range and quality of publications available to our customers.

 

Scaling the Company's sales channels and geographic spread

During H1 2026 Pathos invested in new sales managers, creating more focused teams to support the continued scaling of operations. This is already producing results with new client sign-ups rising by approximately 30% following inception.  In addition the recent annualised run rate of new contracts in the repeats business are tracking at over 75% of the current 2027 revenue market expectation, underpinning Directors' confidence in the business.

 

Pathos also continues to invest in geographic growth with a dedicated APAC operation launched in the period which, although at an early stage, is showing positive signs.  

 

Technological innovation

Testing of Pressella (Pathos's AI 'virtual publicist') indicates that it has at least 7x the success rate of human colleagues in sales development activities. Following the appointment of Scott Feltham as CTO, the Company has expanded both the scope of Pressella's training and the areas of the business in which it operates. The Company remains confident in Pressella and PathosMind achieving general availability in H1 2027.

 

Pathos is also exploring providing Generative Engine Optimisation (GEO) solutions to its customers. This involves structuring customer publications so that AI search tools such as ChatGPT can identify customer articles as primary sources as they process, summarise and cite information.

 

Outlook

The second half of the year has started well, including record revenues in July, and trading to the end of August also significantly ahead of the prior year.  The Board remains confident in performance for the rest of the year and very optimistic about the future.

 

Additional financial information


H1 2026

$m

H1 2025

 $m

Adjusted EBITDA

1.73

1.27

Depreciation and amortisation

(0.50)

(0.35)

Net finance charges

(0.06)

(0.08)

Adjusted profit before tax

1.17

0.84

Adjusting items

-

(0.08)

Share-based payment charge

(0.21)

-

Profit before tax (reported)

0.96

0.76

 

Depreciation, amortisation and finance charges include the Company's office and customer databases, which increased over the prior period due to the impact of the growing investment to underpin future growth.  

 

Adjusted pre-tax profit of $1.2 million was consequently 39% ahead of prior year (H1 2025: $0.8 million).

 

Adjusting items in the prior year comprise initial costs incurred in preparation for admission to the AIM market that subsequently took place in December 2025.

 

The reported profit after tax was $0.9 million (H1 2025: $0.8 million).  Tax charges are low in both years due to the structure of the Group's activities.

 

The Group ended H1 2026  with net cash of $5.9 million at 30 June 2026 (30 June 2025: $0.8 million; 31 December 2025:  $6.2 million).  A summary of the Group's cash flows was as follows:

 


H1 2026

$m

H1 2025

$m

Profit for the period

0.93

0.74

Add back:

 


Amortisation & Depreciation

0.49

0.35

Share-based payments

0.21

-

Finance and tax expenses

0.10

0.09

 

1.73

1.18

Net change in working capital

0.01

(0.04)

Cash generated from operations

1.74

1.14

Purchase of intangible assets

(1.71)

(0.15)

Lease payments

(0.33)

(0.30)

Tax

-

(0.07)

Movement in cash

(0.30)

0.62

Effect of exchange rate changes

(0.02)

(0.03)

Cash at start of the period

6.24

0.22

Cash at end of period

5.92

0.81

 

Capital expenditure mainly comprises investment in intangible assets, including development of the Group's AI platform and purchase of customer databases.

 

Lease payments arise on the Group's main office.

 

Net assets at 30 June 2026 were $7.1 million (30 June 2025: $1.0 million; 31 December 2025: $5.9 million), principally comprising cash balances as the funds raised at IPO are being spent and replaced with strong cash generation in the business.  Other than the office lease the Company has no external debt.



 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME


 

 


 


 

Unaudited


 


 

Six months


Year ended


 

to 30 June


31 December


 

2026


2025


 

 


 


Note

$000


$000






Revenue


7,339


13,083

Cost of sales


(2,132)


(1,224)

(3,299)

Gross profit


5,207


5,196

9,784

Administrative expenses


(4,181)


(10,165)

Operating profit/(loss)


1,026


837

(381)

 


 


 

 

Adjusted EBITDA

4

1,732


1,271

2,871

Depreciation and Amortisation


(496)


(707)

Adjusting items


-


(2,259)

Share-based payments


(210)


-

(286)

Operating profit/(loss)


1,026


837

(381)



 


 

 

Net finance expense


(62)


(145)

Profit/(loss) before tax


964


759

(526)

Tax expense


(39)


(15)

(104)

Profit/(loss) for the period


925


744

(630)

 


 


 

 

Other comprehensive income/(loss):


 


 

Exchange arising on translation on foreign operations (net of tax)


3


(27)

 

(61)

Total comprehensive income/(loss)


928


717

(691)

                                               

Earnings/(loss) per share attributable to the ordinary equity holders of the parent (cents)





 

 

Basic

5

1.39

37,200,000

(7.79)

 

Diluted

5

1.25

37,200,000

(7.79)

 

 




 

 

Adjusted Basic

5

1.70

1.24

2.92

 

Adjusted Diluted

5

1.53

1.12

2.63

 

 

 

 



 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION




 Unaudited

30 June  2026


Unaudited

30 June

 2025

31 December 2025



Note

$000


$000

$000

Assets



 


 

 

Non‑current assets



 


 

 

Property, plant and equipment



1,446


2,006

1,725

Other intangible assets


6

1,970


266

471

Other non‑current investments



17


18

17




3,433


2,290

2,213

Current assets



 


 

 

Trade and other receivables


8

1,329


1,193

934

Cash and cash equivalents



5,916


808

6,241




7,245


2,001

7,175




 


 

 

Total assets



10,678


4,291

9,388




 


 

 

Liabilities



 


 

 

Non-current liabilities





 

 

Lease liabilities



1,053


1,510

1,351




1,053


1.510

1,351

Current liabilities



 


 

 

Trade and other payables


9

1,986


1,141

1,585

Lease liabilities



589


623

540




2,575


1,764

2,125

Total liabilities



3,628


3,274

3,476

 



 


 

 

Net assets



7,050


1,017

5,912

 

 



 


 

 

Share capital



88


-

88

Share premium



5,983


-

5,983

Foreign exchange reserve



(123)


(91)

(126)

Share-based payment reserve



496


-

286

Retained earnings



606


1,108

(319)

Total equity



7,050


1,017

5,912

 

Total equity and liabilities



10,678


4,291

9,388

 

 



 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY


 

 

 

Share Capital

 

 

 

 

Share premium

 

 

 

Foreign Exchange reserve

 

 

Share- based payment reserve

 

 

 

Retained earnings

 

Total attributable to equity holder of parent


$000

 

$000

 

$000

 

$000

 

$000

 

$000













At 1 January 2025

-

 

-

 

(65)

 

-

 

364

 

299

Profit for the period

-


-

 

-


-


744


744

Other comprehensive loss

-


-


(26)


-


-


(26)

Balance at 30 June 2025

-

 

-

 

(91)

 

-

 

1,108

 

1,107

(Unaudited)












 

 


 


 


 


 


 

At 1 January 2025

-


-


(65)


-


364


299

Loss for the year

-


-


-


-


(630)


(630)

Other comprehensive loss

-


-


(61)


-


-


(61)

Issue of share capital

88


5,983


-


-


-


6,071

Capitalisation/bonus issue

-


-


-


-


(53)


(53)

Share-based payments

-


-


-


286


-


286

At 31 December 2025

88

 

5,983

 

(126)

 

286

 

(319)

 

5,912

Profit for the period

 

 

 

 

 

 

 

 

925

 

925

Other comprehensive income

-

 

-

 

3

 

-

 

-

 

3

Share-based payments

-

 

-

 

-

 

210

 

-

 

210

At 30 June 2026

88

 

5,983

 

(123)

 

496

 

606

 

7,050

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 



 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 



 

Unaudited 6 months to 30 June  2026


Unaudited

6 months to 30 June 2025

Year ended 31 December 2025



$000


$000

$000

Cash flows from operating activities


 


 

 

Profit/(loss) for the period


925


744

(630)

Adjustments for:


 


 

 

Depreciation of property, plant and equipment


279


276

556

Amortisation of intangible fixed assets


217


73

152

Share-based payments


210


-

286

Finance expense


62


78

145

Income tax expense


39


15

104



1,732


1,186

613

Increase in trade and other receivables


(395)


(788)

(530)

Increase in trade and other payables


401


739

1,189

Cash generated from operations


1,738


1,137

1,272

Income taxes paid


-


(71)

(176)

Net cash from operating activities


1,738


1,066

1,096

 

Cash flows from investing activities


 


 

 

Purchase of property, plant, and equipment


-


(9)

(9)

Purchase of intangibles


(1,716)


(140)

(426)

Net cash used in investing activities


(1,716)


(149)

(435)

 


 


 

 

Cash flows from financing activities


 


 

 

Issue of ordinary shares, net of costs


-


-

6,018

Net interest income/(charge) excluding lease charges


1


-

(11)

Payment of lease liabilities


(326)


(301)

(596)

Net cash from financing activities


(325)


(301)

5,411

 

Change in cash and cash equivalents in the period


(303)


616

6,072

Effect of exchange rate changes on cash and cash equivalents


(22)


(27)

(50)

Cash and cash equivalents at the beginning of year


6,241


219

219

Cash and cash equivalents at the end of the period


5,916


808

6,241

 

 



 

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

 

1.     Basis of preparation and approval of interim statements


The financial information for the six months ended 30 June 2026 and for the six months ended 30 June 2025 is unaudited.  The interim financial statements for the six months to 30 June 2026 do not include all of the information required for full annual financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended 31 December 2025.

 

The financial information has been prepared on the basis of UK adopted international accounting standards (IFRS) that the Directors expect to be applicable as at 31 December 2026.

 

The accounting policies adopted in the preparation of the interim financial statements are consistent with those set out in the Group's Annual Report and Financial Statements 2025 ('Annual Report'), which were prepared in accordance with IFRS.

 

This interim financial statement does not comprise statutory accounts within the meaning of Section 435 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2025 were approved by the Board on 4 May 2026 and delivered to the Registrar of Companies. The report of the auditor on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 498(2) or Section 498(3) of the Companies Act 2006.

 

AIM-quoted companies are not required to comply with IAS 34 'Interim Financial Reporting' and accordingly the Company has not applied this standard in preparing this report.

 

The interim financial statement was approved by the Board of Directors on 8 September 2026.

 

2.     International Financial Reporting Standards

The Group follows the standards and interpretations issued by the International Accounting Standards Board (IASB) and the International Financial Reporting Interpretations Committee of the IASB and endorsed by the UK that are relevant to its operations.

 

3.     Going concern

The Group's business activities together with factors likely to affect its future development, performance, position  and principal risks and uncertainties were set out in the Strategic Report section of the Annual Report. The Directors have reviewed the cash flow forecasts for the period up to and including 31 December 2027. Based on the above, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future and for at least twelve months from the publication date of these interim financial statements. For this reason the Directors continue to adopt the going concern basis in preparing the interim financial statements.

 

4.     Measures of profit

To provide shareholders with a better understanding of the trading performance of the Group, alternative performance measures (APMs) are included to adjust for items which can distort the underlying performance of the Group.  A reconciliation of reported items to the adjusted items is set out below:



 

 

 


Unaudited

Six months to 30 June

2026

Unaudited

Six months to

30 June

2025

 

Year ended

31 December 2025


$000

$000

$000


 

 

 

Profit/(loss) before tax

964

759

(526)

Adjusting items

-

85

2,259

Share-based payments

210

-

286

Adjusted profit before tax

1,174

844

2,019

Depreciation and amortisation

496

349

707

Net finance costs

62

78

145

Adjusted EBITDA

1,732

1,271

2,871

 

Adjusting items in 2025 comprise initial costs incurred in preparation for admission to the AIM market that subsequently took place in December 2025.

 

Adjustments to earnings/(loss) per share calculations are set out in Note 5.

 

5.     Earnings/(loss) per share

Earnings/(loss) per share is calculated based on the information set out below. The adjusted weighted average shares in 2025 is based on assuming the same number of shares were in issue for the entire year.  Diluted basic loss per share in 2025 is the same as Reported loss per share as, under IAS 33 Earnings per share, conversion of shares is not considered dilutive as it would not increase the loss per share.

 

Earnings

Unaudited

Six months to 30 June

2026

Unaudited

Six months to

30 June

2025

 

Year ended

 31 December

2025

 

$000

$000

$000

 

 

 

 

Profit/(loss) for the period

925

744

(630)

Adjusting items, including share-based payments

210

85

 

2,546

Tax on Adjusting items

-

(1)

28

Adjusted Earnings

1,135

828

1,944

 

Weighted Average Shares (Number)

 

 

 

 

 

 

 

 

Basic

Reported

66,666,666

2

8,083,712


Adjustments

-

66,666,664

58,582,954


Adjusted

66,666,666

66,666,666

66,666,666



 

 

 

Diluted

Reported

74,046,662

2

15,463,708


Adjustments

-

74,046,660

58,582,954


Adjusted

74,046,662

74,046,662

74,046,662

 

 

 

Earnings/(loss) per share (Cents)

 

 

 

 

 

 

 

 

Reported

Basic

1.39

37,200,000

(7.79)


Diluted

1.25

37,200,000

(7.79)




 

 

Adjusted

Basic

1.70

1.24

2.92


Diluted

1.53

1.12

2.63

 

6.     Intangible assets


Contact databases

Computer Software

 

Total


$000

$000

$000

Cost




At 31 December 2024

223

72

295

Additions in year to 31 December 2025

149

277

426

At 31 December 2025

372

349

721

Additions in period

832

884

1,716

At 30 June 2026

1,204

1,233

2,437





Accumulated amortisation and impairment



 

At 31 December 2024

74

24

98

Charge for year to 31 December 2025

92

60

152

At 31 December 2025

166

84

250

Charge for the period

155

62

217

At 30 June 2026

321

146

467

 




Net book value




At 30 June 2025

151

115

266

At 31 December 2025

206

265

471

At 30 June 2026

883

1,087

1,970

 

Computer software comprises amounts relating to the development of the Group's proprietary AI tools.

 

7.     Right of use assets

The right of use asset is in respect of the Group's office lease.

 

8.     Trade and other receivables


Unaudited

30 June

2026

$000

Unaudited

30 June

2025

$000

 

31 December 2025

$000

Current

 

 

 

Trade receivables

955

4,875

2,897

Less: provision for impairment of trade receivables

(626)

(4,040)

(2,644)

Trade receivables - net

329

835

253

Prepayments and accrued income

723

196

338

Other receivables

277 

162

343

Total current trade and other receivables

1,329

1,193

934

 

 

Taking account of the profile and age of the 30 June 2026 receivables, the Group has applied the following average provisions to each age group, which are based on the IFRS 9 simplified approach to measuring expected credit losses using a lifetime expected credit loss provision, grouping receivables based on similar credit risk:

 

$000

0-3 months

4-6 months

7-9        months

 > 9 months

Total

Gross receivables

415

181

199

160

955

Provision %

25%

91%

99%

100%


Provision

104

165

197

160

626

Net receivables

311

16

2

-

329

 

In the 6 months to 30 June 2026 the charge to the P&L account for bad debts was $0.3 million (6 months to 30 June 2025 $1.6 million).  The significant reduction follows the embedding of a comprehensive programme of process and governance enhancements from April 2025.

 

At 31 December 2025, the Group provided 100% on balances > 9 months old, 99% on balances 7-9 months old, 85% on balances 4-6 months old and 27% on balances 0-3 months old.

9.     Trade and other payables


Unaudited

30 June

 2026

Unaudited

30 June 

2025

31 December 2025


$000

$000

$000

Current

 

 

 

Trade payables

 337

201

773

Other payables

488

802

296

Accruals & deferred income

1,013

9

397

Corporation tax payable

148

129

119

Total current trade and other payables

1,986

1,141

1,585

 

10.    Lease liabilities

 

Lease liabilities at 30 June 2026, 30 June 2025 and 31 December 2025 relate entirely to the Group's main office.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100